Login

Hemcheck | CEO interview, Joen Averstad, CEO, Hemcheck 00:00:00

Share On Facebook Share On Twitter

Hemcheck | CEO interview, Joen Averstad, CEO, Hemcheck

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Leveraging Lessons from Past Crises to Navigate Current Markets | Jorge Paulo Lemann, Co-Founder , 3G Capital.
00:10:00
Updates on OvaSuite®, OvaWatchSM, and EndoCheckTM Discussed in Fireside Chat with CEO| Nicole Sandford, CEO, Aspira Women's Health Inc.
00:10:00
CEO Thomas Hanly Reflects on His 30-Year Journey and Singular Health’s Path Forward | Thomas Hanly, CEO , Singular Health Group Ltd.
00:10:00
Clients enjoy senior level attention at every stage of execution.|Paul Delaney, Head of private equity,The Griffin Private Equity Group
00:00:00
Facial Paralysis: Is Surgery Necessary - Samir Mardini, M.D. Facial Plastic Surgeon, Mayo clinic
00:00:00
Dr. Stephen Mcleod, CEO of the American Academy of Ophthalmology
00:10:00
David Azerad discusses his contribution to the paleoconservative anthology and his relationship with Paul Gottfried.|David Azerrad,Professor,Hillsdale College
00:10:00
Wilson Romanini Discusses Vittia’s IPO, Career Journey, and Future Prospects | Wilson Romanini, CEO, Vittia Fertilizantes e Biológicos SA.
00:10:00
Secure 2.0 Brings Key Changes to RMD Rules for Government Plans in 2024
00:10:00
Focusing on Client-Centered Financial Conversations for Long-Term Goals | Penny Pennington, Managing Partner , Edward Jones Investments.
00:10:00
Introduction to Howard Klein of RK Equity and His Insights on the Lithium Industry
00:10:00
Mike Speetzen, CEO of Polaris, joins 'Closing Bell: Overtime' to discuss investor day, earnings, and the state of the high-ticket consumer market.

© 2017 - Neuhu+